Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 529 to 540 of 540 entries
Sorted by: Best Match Show Resources per page
Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders.

Tobacco control

Talukder SR, Lappin JM, Boland V, McRobbie H, Courtney RJ.
PMID: 34862325
Tob Control. 2021 Dec 03; doi: 10.1136/tobaccocontrol-2021-056843. Epub 2021 Dec 03.

OBJECTIVES: People suffering from mental health disorder (MHDs) are often under-represented in clinical research though the reasons for their exclusion are rarely recorded. As they have higher rates of smoking and nicotine dependence, it is crucial that they are...

Cite
Talukder SR, Lappin JM, Boland V, et al. Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders. Tob Control. 2021;doi: 10.1136/tobaccocontrol-2021-056843.
Talukder, S. R., Lappin, J. M., Boland, V., McRobbie, H., & Courtney, R. J. (2021). Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders. Tobacco control, . https://doi.org/10.1136/tobaccocontrol-2021-056843
Talukder, Saki Rubaiya, et al. "Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders." Tobacco control vol. (2021). doi: https://doi.org/10.1136/tobaccocontrol-2021-056843
Talukder SR, Lappin JM, Boland V, McRobbie H, Courtney RJ. Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders. Tob Control. 2021 Dec 03; doi: 10.1136/tobaccocontrol-2021-056843. Epub 2021 Dec 03. PMID: 34862325.
Copy Download .nbib Format: NLM
On Placental Toxicology Studies and Cerium Dioxide Nanoparticles.

International journal of molecular sciences

Deval G, Boland S, Fournier T, Ferecatu I.
PMID: 34830142
Int J Mol Sci. 2021 Nov 12;22(22). doi: 10.3390/ijms222212266.

The human placenta is a transient organ essential for pregnancy maintenance, fetal development and growth. It has several functions, including that of a selective barrier against pathogens and xenobiotics from maternal blood. However, some pollutants can accumulate in the...

Cite
Deval G, Boland S, Fournier T, et al. On Placental Toxicology Studies and Cerium Dioxide Nanoparticles. Int J Mol Sci. 2021;22(22)doi: 10.3390/ijms222212266.
Deval, G., Boland, S., Fournier, T., & Ferecatu, I. (2021). On Placental Toxicology Studies and Cerium Dioxide Nanoparticles. International journal of molecular sciences, 22(22), . https://doi.org/10.3390/ijms222212266
Deval, Gaëlle, et al. "On Placental Toxicology Studies and Cerium Dioxide Nanoparticles." International journal of molecular sciences vol. 22,22 (2021). doi: https://doi.org/10.3390/ijms222212266
Deval G, Boland S, Fournier T, Ferecatu I. On Placental Toxicology Studies and Cerium Dioxide Nanoparticles. Int J Mol Sci. 2021 Nov 12;22(22). doi: 10.3390/ijms222212266. PMID: 34830142; PMCID: PMC8624015.
Copy Download .nbib Format: NLM
Molecular pathways in the development of HPV-induced cervical cancer.

EXCLI journal

Rasi Bonab F, Baghbanzadeh A, Ghaseminia M, Bolandi N, Mokhtarzadeh A, Amini M, Dadashzadeh K, Hajiasgharzadeh K, Baradaran B, Bannazadeh Baghi H.
PMID: 33746665
EXCLI J. 2021 Feb 12;20:320-337. doi: 10.17179/excli2021-3365. eCollection 2021.

Recently, human papillomavirus (HPV) has gained considerable attention in cervical cancer research studies. It is one of the most important sexually transmitted diseases that can affect 160 to 289 out of 10000 persons every year. Due to the infectious...

Cite
Rasi Bonab F, Baghbanzadeh A, Ghaseminia M, et al. Molecular pathways in the development of HPV-induced cervical cancer. EXCLI J. 2021;20:320-337doi: 10.17179/excli2021-3365.
Rasi Bonab, F., Baghbanzadeh, A., Ghaseminia, M., Bolandi, N., Mokhtarzadeh, A., Amini, M., Dadashzadeh, K., Hajiasgharzadeh, K., Baradaran, B., & Bannazadeh Baghi, H. (2021). Molecular pathways in the development of HPV-induced cervical cancer. EXCLI journal, 20320-337. https://doi.org/10.17179/excli2021-3365
Rasi Bonab, Farnaz, et al. "Molecular pathways in the development of HPV-induced cervical cancer." EXCLI journal vol. 20 (2021): 320-337. doi: https://doi.org/10.17179/excli2021-3365
Rasi Bonab F, Baghbanzadeh A, Ghaseminia M, Bolandi N, Mokhtarzadeh A, Amini M, Dadashzadeh K, Hajiasgharzadeh K, Baradaran B, Bannazadeh Baghi H. Molecular pathways in the development of HPV-induced cervical cancer. EXCLI J. 2021 Feb 12;20:320-337. doi: 10.17179/excli2021-3365. eCollection 2021. PMID: 33746665; PMCID: PMC7975633.
Copy Download .nbib Format: NLM
MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects.

Human genetics

Coursimault J, Guerrot AM, Morrow MM, Schramm C, Zamora FM, Shanmugham A, Liu S, Zou F, Bilan F, Le Guyader G, Bruel AL, Denommé-Pichon AS, Faivre L, Tran Mau-Them F, Tessarech M, Colin E, El Chehadeh S, Gérard B, Schaefer E, Cogne B, Isidor B, Nizon M, Doummar D, Valence S, Héron D, Keren B, Mignot C, Coutton C, Devillard F, Alaix AS, Amiel J, Colleaux L, Munnich A, Poirier K, Rio M, Rondeau S, Barcia G, Callewaert B, Dheedene A, Kumps C, Vergult S, Menten B, Chung WK, Hernan R, Larson A, Nori K, Stewart S, Wheless J, Kresge C, Pletcher BA, Caumes R, Smol T, Sigaudy S, Coubes C, Helm M, Smith R, Morrison J, Wheeler PG, Kritzer A, Jouret G, Afenjar A, Deleuze JF, Olaso R, Boland A, Poitou C, Frebourg T, Houdayer C, Saugier-Veber P, Nicolas G, Lecoquierre F.
PMID: 34748075
Hum Genet. 2022 Jan;141(1):65-80. doi: 10.1007/s00439-021-02383-z. Epub 2021 Nov 08.

Pathogenic variants of the myelin transcription factor-1 like (MYT1L) gene include heterozygous missense, truncating variants and 2p25.3 microdeletions and cause a syndromic neurodevelopmental disorder (OMIM#616,521). Despite enrichment in de novo mutations in several developmental disorders and autism studies, the...

Cite
Coursimault J, Guerrot AM, Morrow MM, et al. MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Hum Genet. 2021;141(1):65-80doi: 10.1007/s00439-021-02383-z.
Coursimault, J., Guerrot, A. M., Morrow, M. M., Schramm, C., Zamora, F. M., Shanmugham, A., Liu, S., Zou, F., Bilan, F., Le Guyader, G., Bruel, A. L., Denommé-Pichon, A. S., Faivre, L., Tran Mau-Them, F., Tessarech, M., Colin, E., El Chehadeh, S., Gérard, B., Schaefer, E., Cogne, B., Isidor, B., Nizon, M., Doummar, D., Valence, S., Héron, D., Keren, B., Mignot, C., Coutton, C., Devillard, F., Alaix, A. S., Amiel, J., Colleaux, L., Munnich, A., Poirier, K., Rio, M., Rondeau, S., Barcia, G., Callewaert, B., Dheedene, A., Kumps, C., Vergult, S., Menten, B., Chung, W. K., Hernan, R., Larson, A., Nori, K., Stewart, S., Wheless, J., Kresge, C., Pletcher, B. A., Caumes, R., Smol, T., Sigaudy, S., Coubes, C., Helm, M., Smith, R., Morrison, J., Wheeler, P. G., Kritzer, A., Jouret, G., Afenjar, A., Deleuze, J. F., Olaso, R., Boland, A., Poitou, C., Frebourg, T., Houdayer, C., Saugier-Veber, P., Nicolas, G., & Lecoquierre, F. (2022). MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Human genetics, 141(1), 65-80. https://doi.org/10.1007/s00439-021-02383-z
Coursimault, Juliette, et al. "MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects." Human genetics vol. 141,1 (2022): 65-80. doi: https://doi.org/10.1007/s00439-021-02383-z
Coursimault J, Guerrot AM, Morrow MM, Schramm C, Zamora FM, Shanmugham A, Liu S, Zou F, Bilan F, Le Guyader G, Bruel AL, Denommé-Pichon AS, Faivre L, Tran Mau-Them F, Tessarech M, Colin E, El Chehadeh S, Gérard B, Schaefer E, Cogne B, Isidor B, Nizon M, Doummar D, Valence S, Héron D, Keren B, Mignot C, Coutton C, Devillard F, Alaix AS, Amiel J, Colleaux L, Munnich A, Poirier K, Rio M, Rondeau S, Barcia G, Callewaert B, Dheedene A, Kumps C, Vergult S, Menten B, Chung WK, Hernan R, Larson A, Nori K, Stewart S, Wheless J, Kresge C, Pletcher BA, Caumes R, Smol T, Sigaudy S, Coubes C, Helm M, Smith R, Morrison J, Wheeler PG, Kritzer A, Jouret G, Afenjar A, Deleuze JF, Olaso R, Boland A, Poitou C, Frebourg T, Houdayer C, Saugier-Veber P, Nicolas G, Lecoquierre F. MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Hum Genet. 2022 Jan;141(1):65-80. doi: 10.1007/s00439-021-02383-z. Epub 2021 Nov 08. PMID: 34748075.
Copy Download .nbib Format: NLM
Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions.

Chemosphere

Han H, Wu X, Bolan N, Kirkham MB, Yang J, Chen Z.
PMID: 34999099
Chemosphere. 2022 Jan 06;293:133534. doi: 10.1016/j.chemosphere.2022.133534. Epub 2022 Jan 06.

In heavy metal-contaminated farmland, microorganisms or organic fertilizers can be used to minimize heavy metal uptake by crops to ensure food safety. However, the mechanisms by which urease-producing and metal-immobilizing bacteria combined with manure inhibit Cd uptake in wheat...

Cite
Han H, Wu X, Bolan N, et al. Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere. 2022;293:133534doi: 10.1016/j.chemosphere.2022.133534.
Han, H., Wu, X., Bolan, N., Kirkham, M. B., Yang, J., & Chen, Z. (2022). Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere, 293133534. https://doi.org/10.1016/j.chemosphere.2022.133534
Han, Hui, et al. "Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions." Chemosphere vol. 293 (2022): 133534. doi: https://doi.org/10.1016/j.chemosphere.2022.133534
Han H, Wu X, Bolan N, Kirkham MB, Yang J, Chen Z. Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere. 2022 Jan 06;293:133534. doi: 10.1016/j.chemosphere.2022.133534. Epub 2022 Jan 06. PMID: 34999099.
Copy Download .nbib Format: NLM
Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions.

Chemosphere

Han H, Wu X, Bolan N, Kirkham MB, Yang J, Chen Z.
PMID: 34999099
Chemosphere. 2022 Jan 06;293:133534. doi: 10.1016/j.chemosphere.2022.133534. Epub 2022 Jan 06.

In heavy metal-contaminated farmland, microorganisms or organic fertilizers can be used to minimize heavy metal uptake by crops to ensure food safety. However, the mechanisms by which urease-producing and metal-immobilizing bacteria combined with manure inhibit Cd uptake in wheat...

Cite
Han H, Wu X, Bolan N, et al. Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere. 2022;293:133534doi: 10.1016/j.chemosphere.2022.133534.
Han, H., Wu, X., Bolan, N., Kirkham, M. B., Yang, J., & Chen, Z. (2022). Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere, 293133534. https://doi.org/10.1016/j.chemosphere.2022.133534
Han, Hui, et al. "Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions." Chemosphere vol. 293 (2022): 133534. doi: https://doi.org/10.1016/j.chemosphere.2022.133534
Han H, Wu X, Bolan N, Kirkham MB, Yang J, Chen Z. Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere. 2022 Jan 06;293:133534. doi: 10.1016/j.chemosphere.2022.133534. Epub 2022 Jan 06. PMID: 34999099.
Copy Download .nbib Format: NLM
Trikafta Rescues CFTR and Lowers Monocyte P2X7R-Induced Inflammasome Activation in Cystic Fibrosis.

American journal of respiratory and critical care medicine

Gabillard-Lefort C, Casey M, Glasgow AMA, Boland F, Kerr O, Marron E, Lyons AM, Gunaratnam C, McElvaney NG, Reeves EP.
PMID: 35021019
Am J Respir Crit Care Med. 2022 Jan 12; doi: 10.1164/rccm.202106-1426OC. Epub 2022 Jan 12.

RATIONALE: Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene and is characterized by sustained inflammation. Adenosine-5'-Triphosphate (ATP) triggers interleukin (IL)-1β secretion via the P2X7 receptor (P2X7R) and activation of the NLRP3 (NOD-,...

Cite
Gabillard-Lefort C, Casey M, Glasgow AMA, et al. Trikafta Rescues CFTR and Lowers Monocyte P2X7R-Induced Inflammasome Activation in Cystic Fibrosis. Am J Respir Crit Care Med. 2022;doi: 10.1164/rccm.202106-1426OC.
Gabillard-Lefort, C., Casey, M., Glasgow, A. M. A., Boland, F., Kerr, O., Marron, E., Lyons, A. M., Gunaratnam, C., McElvaney, N. G., & Reeves, E. P. (2022). Trikafta Rescues CFTR and Lowers Monocyte P2X7R-Induced Inflammasome Activation in Cystic Fibrosis. American journal of respiratory and critical care medicine, . https://doi.org/10.1164/rccm.202106-1426OC
Gabillard-Lefort, Claudie, et al. "Trikafta Rescues CFTR and Lowers Monocyte P2X7R-Induced Inflammasome Activation in Cystic Fibrosis." American journal of respiratory and critical care medicine vol. (2022). doi: https://doi.org/10.1164/rccm.202106-1426OC
Gabillard-Lefort C, Casey M, Glasgow AMA, Boland F, Kerr O, Marron E, Lyons AM, Gunaratnam C, McElvaney NG, Reeves EP. Trikafta Rescues CFTR and Lowers Monocyte P2X7R-Induced Inflammasome Activation in Cystic Fibrosis. Am J Respir Crit Care Med. 2022 Jan 12; doi: 10.1164/rccm.202106-1426OC. Epub 2022 Jan 12. PMID: 35021019.
Copy Download .nbib Format: NLM
Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions.

Chemosphere

Han H, Wu X, Bolan N, Kirkham MB, Yang J, Chen Z.
PMID: 34999099
Chemosphere. 2022 Jan 06;133534. doi: 10.1016/j.chemosphere.2022.133534. Epub 2022 Jan 06.

In heavy metal-contaminated farmland, microorganisms or organic fertilizers can be used to minimize heavy metal uptake by crops to ensure food safety. However, the mechanisms by which urease-producing and metal-immobilizing bacteria combined with manure inhibit Cd uptake in wheat...

Cite
Han H, Wu X, Bolan N, et al. Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere. 2022;133534doi: 10.1016/j.chemosphere.2022.133534.
Han, H., Wu, X., Bolan, N., Kirkham, M. B., Yang, J., & Chen, Z. (2022). Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere, 133534. https://doi.org/10.1016/j.chemosphere.2022.133534
Han, Hui, et al. "Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions." Chemosphere vol. (2022): 133534. doi: https://doi.org/10.1016/j.chemosphere.2022.133534
Han H, Wu X, Bolan N, Kirkham MB, Yang J, Chen Z. Inhibition of cadmium uptake by wheat with urease-producing bacteria combined with sheep manure under field conditions. Chemosphere. 2022 Jan 06;133534. doi: 10.1016/j.chemosphere.2022.133534. Epub 2022 Jan 06. PMID: 34999099.
Copy Download .nbib Format: NLM
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Lukin D, Faleck D, Xu R, Zhang Y, Weiss A, Aniwan S, Kadire S, Tran G, Rahal M, Winters A, Chablaney S, Koliani-Pace JL, Meserve J, Campbell JP, Kochhar G, Bohm M, Varma S, Fischer M, Boland B, Singh S, Hirten R, Ungaro R, Lasch K, Shmidt E, Jairath V, Hudesman D, Chang S, Swaminath A, Shen B, Kane S, Loftus EV, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS.
PMID: 33039584
Clin Gastroenterol Hepatol. 2022 Jan;20(1):126-135. doi: 10.1016/j.cgh.2020.10.003. Epub 2020 Oct 08.

BACKGROUND & AIMS: We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice.METHODS: A multicenter, retrospective, observational cohort study (May 2014 to December 2017) of ulcerative colitis patients...

Cite
Lukin D, Faleck D, Xu R, et al. Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020;20(1):126-135doi: 10.1016/j.cgh.2020.10.003.
Lukin, D., Faleck, D., Xu, R., Zhang, Y., Weiss, A., Aniwan, S., Kadire, S., Tran, G., Rahal, M., Winters, A., Chablaney, S., Koliani-Pace, J. L., Meserve, J., Campbell, J. P., Kochhar, G., Bohm, M., Varma, S., Fischer, M., Boland, B., Singh, S., Hirten, R., Ungaro, R., Lasch, K., Shmidt, E., Jairath, V., Hudesman, D., Chang, S., Swaminath, A., Shen, B., Kane, S., Loftus, E. V., Sands, B. E., Colombel, J. F., Siegel, C. A., Sandborn, W. J., & Dulai, P. S. (2022). Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 20(1), 126-135. https://doi.org/10.1016/j.cgh.2020.10.003
Lukin, Dana, et al. "Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 20,1 (2022): 126-135. doi: https://doi.org/10.1016/j.cgh.2020.10.003
Lukin D, Faleck D, Xu R, Zhang Y, Weiss A, Aniwan S, Kadire S, Tran G, Rahal M, Winters A, Chablaney S, Koliani-Pace JL, Meserve J, Campbell JP, Kochhar G, Bohm M, Varma S, Fischer M, Boland B, Singh S, Hirten R, Ungaro R, Lasch K, Shmidt E, Jairath V, Hudesman D, Chang S, Swaminath A, Shen B, Kane S, Loftus EV, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022 Jan;20(1):126-135. doi: 10.1016/j.cgh.2020.10.003. Epub 2020 Oct 08. PMID: 33039584; PMCID: PMC8026779.
Copy Download .nbib Format: NLM
Printed Electronic Devices with Inks of TiS.

ACS applied materials & interfaces

Baraghani S, Abourahma J, Barani Z, Mohammadzadeh A, Sudhindra S, Lipatov A, Sinitskii A, Kargar F, Balandin AA.
PMID: 34553916
ACS Appl Mater Interfaces. 2021 Oct 06;13(39):47033-47042. doi: 10.1021/acsami.1c12948. Epub 2021 Sep 23.

We report on the fabrication and characterization of electronic devices printed with inks of quasi-one-dimensional (1D) van der Waals materials. The quasi-1D van der Waals materials are characterized by 1D motifs in their crystal structure, which allow for their...

Cite
Baraghani S, Abourahma J, Barani Z, et al. Printed Electronic Devices with Inks of TiS. ACS Appl Mater Interfaces. 2021;13(39):47033-47042doi: 10.1021/acsami.1c12948.
Baraghani, S., Abourahma, J., Barani, Z., Mohammadzadeh, A., Sudhindra, S., Lipatov, A., Sinitskii, A., Kargar, F., & Balandin, A. A. (2021). Printed Electronic Devices with Inks of TiS. ACS applied materials & interfaces, 13(39), 47033-47042. https://doi.org/10.1021/acsami.1c12948
Baraghani, Saba, et al. "Printed Electronic Devices with Inks of TiS." ACS applied materials & interfaces vol. 13,39 (2021): 47033-47042. doi: https://doi.org/10.1021/acsami.1c12948
Baraghani S, Abourahma J, Barani Z, Mohammadzadeh A, Sudhindra S, Lipatov A, Sinitskii A, Kargar F, Balandin AA. Printed Electronic Devices with Inks of TiS. ACS Appl Mater Interfaces. 2021 Oct 06;13(39):47033-47042. doi: 10.1021/acsami.1c12948. Epub 2021 Sep 23. PMID: 34553916.
Copy Download .nbib Format: NLM
Type 2 immunity is maintained during cancer-associated adipose tissue wasting.

Immunotherapy advances

Lenehan PJ, Cirella A, Uchida AM, Crowley SJ, Sharova T, Boland G, Dougan M, Dougan SK, Heckler M.
PMID: 34291232
Immunother Adv. 2021 Jun 02;1(1):ltab011. doi: 10.1093/immadv/ltab011. eCollection 2021 Jan.

OBJECTIVES: Cachexia is a systemic metabolic disorder characterized by loss of fat and muscle mass, which disproportionately impacts patients with gastrointestinal malignancies such as pancreatic cancer. While the immunologic shifts contributing to the development of other adipose tissue (AT)...

Cite
Lenehan PJ, Cirella A, Uchida AM, et al. Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunother Adv. 2021;1(1):ltab011doi: 10.1093/immadv/ltab011.
Lenehan, P. J., Cirella, A., Uchida, A. M., Crowley, S. J., Sharova, T., Boland, G., Dougan, M., Dougan, S. K., & Heckler, M. (2021). Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunotherapy advances, 1(1), ltab011. https://doi.org/10.1093/immadv/ltab011
Lenehan, Patrick J, et al. "Type 2 immunity is maintained during cancer-associated adipose tissue wasting." Immunotherapy advances vol. 1,1 (2021): ltab011. doi: https://doi.org/10.1093/immadv/ltab011
Lenehan PJ, Cirella A, Uchida AM, Crowley SJ, Sharova T, Boland G, Dougan M, Dougan SK, Heckler M. Type 2 immunity is maintained during cancer-associated adipose tissue wasting. Immunother Adv. 2021 Jun 02;1(1):ltab011. doi: 10.1093/immadv/ltab011. eCollection 2021 Jan. PMID: 34291232; PMCID: PMC8286632.
Copy Download .nbib Format: NLM
BUILDing SCHOLARS: Enhancing diversity among U.S. biomedical researchers in the Southwest.

Grineski SE, Collins TW, Aley SB, Boland T, Corral G, Cox MB, Echegoyen LE, Morera OF, Nazeran H.
UIID-AD: 4786
2017; doi: 10.1186/s12919-017-0095-4.

Background and purpose: With funding from the National Institutes of Health, BUILDing SCHOLARS was established at The University of Texas at El Paso with the goal of implementing, evaluating and sustaining a suite of institutional, faculty and student development...

Cite
Grineski SE, Collins TW, Aley SB, et al. BUILDing SCHOLARS: Enhancing diversity among U.S. biomedical researchers in the Southwest. 2017;doi: 10.1186/s12919-017-0095-4.
Grineski, S. E., Collins, T. W., Aley, S. B., Boland, T., Corral, G., Cox, M. B., Echegoyen, L. E., Morera, O. F., & Nazeran, H. (2017). BUILDing SCHOLARS: Enhancing diversity among U.S. biomedical researchers in the Southwest. . https://doi.org/10.1186/s12919-017-0095-4
Grineski, S E, et al. "BUILDing SCHOLARS: Enhancing diversity among U.S. biomedical researchers in the Southwest." vol. (2017). doi: https://doi.org/10.1186/s12919-017-0095-4
Grineski SE, Collins TW, Aley SB, Boland T, Corral G, Cox MB, Echegoyen LE, Morera OF, Nazeran H. BUILDing SCHOLARS: Enhancing diversity among U.S. biomedical researchers in the Southwest. 2017; doi: 10.1186/s12919-017-0095-4. UIID-AD: 4786.
Copy Download .nbib Format: NLM
Showing 529 to 540 of 540 entries